CoChat

Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A 1c and treatment modality

Open access
Birkebaek, NH, Drivvoll, AK, Aakeson, K, Bjarnason, R, Johansen, A, Samuelsson, U, Skrivarhaug, T, Thorsson, AV, Svensson, J · 2017 · BMJ Open Diabetes Research & Care
Cited by 51

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: Treatment of type 1 diabetes has been intensified aiming at normalizing blood glucose, which may increase the risk of severe hypoglycemia (SH). We aimed to compare the incidence of SH events in the four Nordic countries Denmark, Iceland, Norway and Sweden, and to assess the influence of hemoglobin A1c (HbA 1c) and treatment modalities on the frequency of SH; particularly, to explore if a HbA 1c target ≤6.7% (50 mmol/mol) is feasible. Research design and methods: Data on children below 15 years with a diabetes duration more than 1 year, registered in the national childhood diabetes databases in the four Nordic countries from 2008 to 2012, were compiled. Data completeness was more than 95%. Results: Totally 8806 (48% females) patients with 29 715 person years were included, mean age and diabetes duration were 11 years and 5.1 years, respectively. The overall rate of SH was 6.0 per 100 patient-years, and did not change during the study period. The Swedish population constantly had the lowest SH incidence while it decreased significantly in the Danish population. HbA 1c decreased significantly over time (p<0.01), while the number of pump users increased (p<0.01). Stratifying for HbA 1c levels showed the lowest risk of SH in patients with HbA 1c ≤6.7% (≤50 mmol/mol), but in the statistical models adjusting for possible confounders the difference between the HbA 1c groups disappeared. Pump users had the lowest SH risk, also after adjusting for possible confounders. Conclusions: Risk of SH differs between the Nordic countries with the lowest risk in Sweden. Pump therapy was associated with decreased risk of SH. The low HbA 1c group had the same or a lower risk of SH compared with the highest HbA 1c groups. A target HbA 1c ≤6.7% (≤50 mmol/mol) seems achievable without increasing the risk of SH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjdrc-2016-000377

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 51

Metadata

Authors
Birkebaek, N., Drivvoll, A., Aakeson, K., Bjarnason, R., Johansen, A., Samuelsson, U., Skrivarhaug, T., Thorsson, A., & Svensson, J.
Venue
BMJ Open Diabetes Research & Care
Publisher
BMJ
Published
2017-05
Volume
5
Issue
1
Pages
e000377
ISSN
2052-4897 (ISSN-L)
OpenAlex
W2617402021
Cited by
51
References
8
FWCI
4.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A 1c and treatment modality. https://app.cochat.ai/papers/10.1136/bmjdrc-2016-000377
The paper
Birkebaek, N., Drivvoll, A., Aakeson, K., Bjarnason, R., Johansen, A., Samuelsson, U., Skrivarhaug, T., Thorsson, A., & Svensson, J. (2017). Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008–2012: association with hemoglobin A 1c and treatment modality. BMJ Open Diabetes Research & Care. https://doi.org/10.1136/bmjdrc-2016-000377

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.